Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8807234 | Annals of Diagnostic Pathology | 2018 | 39 Pages |
Abstract
HS must be differentiated from other malignant histiocytoid lesions. Staining for common leukocyte antigen and CD163 are the most reliable markers allowing this distinction. Patients who present with primary involvement of the skin may have a favorable outcome but only if treated relatively early in the course of the disease with complete excision.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Cynthia M. Magro, Najiyah Kazi, Aimee E. Sisinger,